高级搜索
Ⅳa 期鼻咽癌治疗中不同化疗周期的疗效分析[J]. 肿瘤防治研究, 2007, 34(11): 881-882. DOI: 10.3971/j.issn.1000-8578.67
引用本文: Ⅳa 期鼻咽癌治疗中不同化疗周期的疗效分析[J]. 肿瘤防治研究, 2007, 34(11): 881-882. DOI: 10.3971/j.issn.1000-8578.67
Comparison of Different Cycles Chemotherapy for Staging Ⅳa Nasopharyngeal[J]. Cancer Research on Prevention and Treatment, 2007, 34(11): 881-882. DOI: 10.3971/j.issn.1000-8578.67
Citation: Comparison of Different Cycles Chemotherapy for Staging Ⅳa Nasopharyngeal[J]. Cancer Research on Prevention and Treatment, 2007, 34(11): 881-882. DOI: 10.3971/j.issn.1000-8578.67

Ⅳa 期鼻咽癌治疗中不同化疗周期的疗效分析

Comparison of Different Cycles Chemotherapy for Staging Ⅳa Nasopharyngeal

  • 摘要: 目的 对比观察不同化疗周期治疗Ⅳa期鼻咽癌生存率的影响。方法 100例Ⅳa期鼻咽癌患者随机分为两组,两组放疗方式及化疗方案相同,均用标准超分割方式放疗,总DT72~76.8Gy。对照组在放疗前、放疗中加用化疗,共化疗2周期;治疗组在放疗前、放疗中及放疗结束后加用化疗,共化疗4周期。结果 治疗组和对照组的5年总生存率分别为50%、40%;两组的无瘤生存率为44%和38%。治疗组和对照组的远地转移率分别为46%和56%。结论 两组生存率和远地转移率无明显差异,放疗结束后继续化疗有可能会提高生存率。

     

    Abstract: Objective  To compare the survival rate of different cycles chemotherapy for the influence of staging Ⅳa nasopharyngeal. Methods  One hundred patient s with staging Ⅳa nasopharyngeal were divided into two group s : treatment group and cont rol group. All patients were given the same radiotherapy (hyperf ractionation radiotherapy, DT : 72~76. 8 Gy) and received chemotherapy of same regimen. Patients in control group received two cycles chemotherapy before and during radiotherapy. Patients in treatment group received four cycles before, during and after radiotherapy. Results  The 52year survival rates of treatment group and control group were 50 % and 40 %, disease-free survival rates were 44 % and 38 %, the distance metastasis rates were 46 % and 56 % respectively. Conclusion  The survival rates and distance metastasis rates in two groups are no significant difference. Continue chemotherapy after radiotherapy may increase the survival rate.

     

/

返回文章
返回